Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Novel Huntington’s Disease Assessment Platform to Support Future Drug Discovery and Development
Jingyun Wu, Luisa Möhle, Thomas Brüning, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14763-14763
Open Access | Times Cited: 18

Showing 18 citing articles:

Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System
Maria Pia Villa, Jingyun Wu, Stefanie Hansen, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 740-740
Open Access | Times Cited: 5
A collaborative network analysis for the interpretation of transcriptomics data in Huntington’s disease
Ozan Özışık, Nazlı Kara, Tooba Abbassi‐Daloii, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Advances in Huntington’s Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review
Sarah Aqel, Jamil Ahmad, Iman Saleh, et al.
Biology (2025) Vol. 14, Iss. 2, pp. 129-129
Open Access
Absence of hippocampal pathology persists in the Q175DN mouse model of Huntington's disease despite elevated HTT aggregation
Michele Solem, Ross Pelzel, Nicholas B. Rozema, et al.
Journal of Huntington s Disease (2025)
Closed Access
Medicinal polypharmacology: Exploration and exploitation of the polypharmacolome in modern drug development
Sven Marcel Stefan, Muhammad Rafehi
Drug Development Research (2023) Vol. 85, Iss. 1
Open Access | Times Cited: 14
Evaluation of cerebrospinal fluid (CSF) and interstitial fluid (ISF) mouse proteomes for the validation and description of Alzheimer’s disease biomarkers
Anna Górska, Irene Santos‐García, Iván Eiriz, et al.
Journal of Neuroscience Methods (2024) Vol. 411, pp. 110239-110239
Open Access | Times Cited: 4
Time- and Sex-Dependent Effects of Fingolimod Treatment in a Mouse Model of Alzheimer’s Disease
Pablo Bascuñana, Mirjam Brackhan, Luisa Möhle, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 331-331
Open Access | Times Cited: 10
HD_BPMDS: a curated binary pattern multitarget dataset of Huntington’s disease–targeting agents
Sven Marcel Stefan, Jens Pahnke, Vigneshwaran Namasivayam
Journal of Cheminformatics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 10
The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington’s disease
J. Pérot, Emmanuel Brouillet, Julien Flament
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 3
Diffusion MRI marks progressive alterations in fiber integrity in the zQ175DN mouse model of Huntington's disease
Nicholas Vidas-Guscic, Joëlle van Rijswijk, Johan Van Audekerke, et al.
Neurobiology of Disease (2024) Vol. 193, pp. 106438-106438
Open Access | Times Cited: 3
Deep behavioural phenotyping of the Q175 Huntington disease mouse model: effects of age, sex, and weight
Ellen T. Koch, Judy Cheng, Daniel Ramandi, et al.
BMC Biology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma
Feimu Fan, Joshua S. Fleishman, Chen Jin, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104069-104069
Closed Access | Times Cited: 3
Medicinal polypharmacology—a scientific glossary of terminology and concepts
Sven Marcel Stefan, Muhammad Rafehi
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
The big data challenge – and how polypharmacology supports the translation from pre-clinical research into clinical use against neurodegenerative diseases and beyond
Sven Marcel Stefan, Muhammad Rafehi
Neural Regeneration Research (2023) Vol. 19, Iss. 8, pp. 1647-1648
Open Access | Times Cited: 8
Enhanced Hippocampal Spare Capacity in Q175DN Mice Despite Elevated mHTT Aggregation
Michele Solem, Ross Pelzel, Nicholas Rozema, et al.
(2024)
Open Access
Sex-Dependent Efficacy of Sphingosine-1-Phosphate Receptor Agonist FTY720 in Mitigating Huntington’s Disease
Jingyun Wu, Irene Santos‐García, Iván Eiriz, et al.
Pharmacological Research (2024), pp. 107557-107557
Open Access
Enrichment analysis of phenotypic data for drug repurposing in rare diseases
Alberto Ambesi‐Impiombato, Kimberly H. Cox, Sylvie Ramboz, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 1
Collaborative network analysis for the interpretation of transcriptomics data in rare diseases, an application to Huntington’s disease
Ozan Özışık, Nazlı Kara, Tooba Abbassi‐Daloii, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top